Showing results (1-10 of 37) with videos related to
Sort By:
Pageof 4
Journal of Receptor and Signal Transduction Research|November 25, 2003
Conformational changes of G protein-coupled receptors during their activation by agonist bindingCaterina BissantzJournal of Chemical Information and Computer Sciences|May 25, 2004
High-throughput modeling of human G-protein coupled receptors: amino acid sequence alignment, three-dimensional model building, and receptor library screeningCaterina Bissantz, Antoine Logean, Didier RognanProteins|December 10, 2002
Protein-based virtual screening of chemical databases. II. Are homology models of G-Protein Coupled Receptors suitable targets?Caterina Bissantz, Philippe Bernard, Marcel Hibert, et al.Proteins|October 15, 2005
Focused library design in GPCR projects on the example of 5-HT(2c) agonists: comparison of structure-based virtual screening with ligand-based search methodsCaterina Bissantz, Claire Schalon, Wolfgang Guba, et al.Archiv Der Pharmazie|July 5, 2012
1,2,4-trisubstituted cyclopentanes as platforms for diversityYousheng Guan, Caterina Bissantz, Donald E Bergstrom, et al.Antimicrobial Agents and Chemotherapy|July 18, 2018
In Vivo Efficacy of Meropenem with a Novel Non-β-Lactam-β-Lactamase Inhibitor, Nacubactam, against Gram-Negative Organisms Exhibiting Various Resistance Mechanisms in a Murine Complicated Urinary Tract Infection ModelMarguerite L Monogue, Sara Giovagnoli, Caterina Bissantz, et al.Molecular Pharmaceutics|May 24, 2023
Estimating Unbound Drug Concentrations in Simulated Human Lung Fluid: Relevance to Lung Antibiotic PKPDJanneke Keemink, Carina Cantrill, William Riboulet, et al.Journal of Medicinal Chemistry|May 12, 2012
Identification of a crucial amino acid in the helix position 6.51 of human tachykinin neurokinin 1 and 3 receptors contributing to the insurmountable mode of antagonism by dual NK₁/NK₃ antagonistsCaterina Bissantz, Claudia Bohnert, Torsten Hoffmann, et al.Molecular Pharmacology|April 21, 2010
Mapping the binding pocket of dual antagonist almorexant to human orexin 1 and orexin 2 receptors: comparison with the selective OX1 antagonist SB-674042 and the selective OX2 antagonist N-ethyl-2-[(6-methoxy-pyridin-3-yl)-(toluene-2-sulfonyl)-amino]-N-pyridin-3-ylmethyl-acetamide (EMPA)Pari Malherbe, Olivier Roche, Anne Marcuz, et al.Medicinal Chemistry (Shariqah (United Arab Emirates))|November 20, 2012
4-Aminocyclopentane-1,3-diols as platforms for diversity: synthesis of anandamide analogsVida Zohrabi-Kalantari, Abbas Jarrahian, Caterina Bissantz, et al.Pageof 4